Funded Startups in Tartu
Across 19 most-recent-funded entries in Tartu (round dates from 2026-05-05 back to 2021-05-18), the largest disclosed round is Gren’s $1.3B on 2026-05-05.
Across 19 most-recent-funded entries in Tartu (round dates from 2026-05-05 back to 2021-05-18), the largest disclosed round is Gren’s $1.3B on 2026-05-05. That disclosed amount dwarfs the next-largest disclosed rounds in the list, such as Icosagen Group’s $19M (2023-02-08) and Solid World DAO’s $3M (2022-05-03), while many other disclosed deals cluster in the $100K–$2M range (for example, Decomer Technology’s $100K on 2022-04-11 and Gearbox Biosciences’s $400K on 2023-10-13).
The most recent activity is concentrated: five of the 19 entries land between 2026-04-23 and 2025-10-04, with multiple biotechnology names appearing in close succession (Chemestmed and Vectiopep on 2026-04-23; Icosagen Group on 2023-02-08; Antegenes on 2022-08-02). Stage disclosure is also uneven: 2 entries are explicitly “undisclosed” by amount (Chemestmed, Vectiopep), and 4 entries show “Series Unknown” as the round type (Gren, Chemestmed, Vectiopep, Menken Trials), shaping how comparably interpretable the later-stage and early-stage mix is in this snapshot.
Most recent rounds
19 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Tartu list, and is it an outlier versus other disclosed amounts?
Gren’s $1.3B on 2026-05-05 is an outlier versus the rest of the disclosed amounts shown. The next-largest disclosed figures are far lower, including Icosagen Group’s $19M (2023-02-08) and Solid World DAO’s $3M (2022-05-03), while several other disclosed rounds sit closer to the $100K–$2M range (e.g., Decomer Technology $100K on 2022-04-11, Remato $2M on 2021-08-11).
How much of the list clusters near the most recent round dates?
Recent rounds cluster into a short window: multiple entries appear from 2026-04-23 (Chemestmed and Vectiopep) through 2025-10-04 (PropShopTrader). Counting the dates in the snapshot, there are entries on 2026-05-05, 2026-04-23 (two companies), 2025-10-04, and 2025-08-14—indicating front-loaded recency rather than a uniform spread across 2026–2021.
Which sectors appear repeatedly across these 19 rows?
Biotechnology is the clear repeated sector, appearing in Chemestmed (undisclosed; 2026-04-23), Vectiopep (undisclosed; 2026-04-23), Gearbox Biosciences ($400K; 2023-10-13), Icosagen Group ($19M; 2023-02-08), Antegenes ($2M; 2022-08-02), Decomer Technology ($100K; 2022-04-11), and Menken Trials is not biotech—so biotech occupies 7 of 19 entries in this view. Agriculture and Farming also repeats (eAgronom, KappaZeta), but less than biotechnology.
Does the stage/amount disclosure pattern limit comparisons in this dataset?
Yes. Two entries have “undisclosed” amounts (Chemestmed and Vectiopep, both dated 2026-04-23), and four entries use “Series Unknown” for the round type (Gren on 2026-05-05; Chemestmed and Vectiopep on 2026-04-23; Menken Trials on 2024-06-17). That combination makes it harder to compare stage-to-stage performance using disclosed amounts alone.
Are there other notable high-amount biotech rounds besides the $1.3B outlier?
Beyond Gren’s $1.3B, the largest disclosed biotech-related amounts in this snapshot include Icosagen Group’s $19M on 2023-02-08 and Antegenes’ $2M on 2022-08-02. Other biotech disclosed rounds shown are smaller, such as Gearbox Biosciences at $400K (2023-10-13) and Decomer Technology at $100K (2022-04-11), reinforcing that Gren is the dominant magnitude outlier.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.